Catalyst Wire Dossier Catalyst Wire Dossier

ANAGRELIDE

Anagrelide · Chartwell RX, LLC
Drug timelines are a Plus or Pro feature.

15 regulatory and trial events tracked for ANAGRELIDE, covering 2009-06-02 to 2025-08-13. Get the full timeline:

Most recent: Clinical Trial Update: Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance [Phase 3]

See pricing